February 18, 2014 Dr. Andrew PecoraStock Option Modification Agreement • March 28th, 2014 • Cancer Genetics, Inc • Services-medical laboratories
CONSULTING AGREEMENTConsulting Agreement • March 28th, 2014 • Cancer Genetics, Inc • Services-medical laboratories • New York
THIS CONSULTING AGREEMENT (the “Agreement”), made this 19th day of February 2014, is entered into by Cancer Genetics, Inc., a Delaware corporation with its principal place of business at 201 State Route 17, Rutherford, New Jersey, 07070 (the “Company”), and R.S.K. Chaganti, Ph.D., with an address at 235 Pascack Road, Hillsdale, NJ 07642 (the “Consultant”).
EMPLOYMENT AGREEMENTEmployment Agreement • March 28th, 2014 • Cancer Genetics, Inc • Services-medical laboratories • New Jersey
This Employment Agreement (this “Agreement”) is entered into as of March 17, 2014 (“Effective Date”), by and between Cancer Genetics, Inc., a Delaware corporation (the “Company”), and Edward J. Sitar (“Employee”).
SEPARATION AND GENERAL RELEASE AGREEMENTSeparation and General Release Agreement • March 28th, 2014 • Cancer Genetics, Inc • Services-medical laboratories • New Jersey
This Separation and General Release Agreement (“Agreement”) is entered into by and between Elizabeth Czerepak (“Employee”) and Cancer Genetics, Inc. a Delaware corporation (“Employer”), on behalf of itself, its members, partners, directors, officers, employees, attorneys, agents, investors, and any subsidiaries and affiliates and any of each of their respective assigns (collectively, the “Released Parties”) in order to further the mutually desired terms and conditions set forth herein.
